Raul H. Sansores

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.

EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.

Journal: Epigenomics

Published: July 23, 2025

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.

Journal: Respiratory medicine

Published: January 22, 2025

Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease.

Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease.

Journal: Medical sciences (Basel, Switzerland)

Published: August 21, 2024

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass.

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass.

Journal: ERJ open research

Published: February 16, 2024

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.

Journal: Heliyon

Published: November 06, 2023

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.

Journal: Respiratory medicine

Published: May 14, 2023

SNPs Sets in Codifying Genes for Xenobiotics-Processing Enzymes Are Associated with COPD Secondary to Biomass-Burning Smoke.

SNPs Sets in Codifying Genes for Xenobiotics-Processing Enzymes Are Associated with COPD Secondary to Biomass-Burning Smoke.

Journal: Current issues in molecular biology

Published: December 09, 2022

Association between chronic obstructive pulmonary disease and biomass smoke in rural areas.

Association between chronic obstructive pulmonary disease and biomass smoke in rural areas.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: November 30, 2022

Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.

Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.

Journal: Respiratory medicine

Published: August 12, 2022

Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: A pilot study.

Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: A pilot study.

Journal: Immunity, inflammation and disease

Published: July 18, 2022

Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations.

Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations.

Journal: ERJ open research

Published: April 12, 2022

Prevalence, attitude, knowledge, and risk perception towards COVID-19 in COPD patients associated to biomass exposure.

Prevalence, attitude, knowledge, and risk perception towards COVID-19 in COPD patients associated to biomass exposure.

Journal: International journal of environmental health research

Published: December 30, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026